We Tested 200+ Peptide Samples: Here's What We Found
This is our dataset, not a literature review. Over 200 samples submitted for verification were analyzed by mass spectrometry for identity and HPLC for purity and content. Below are the aggregate results, the failure modes we saw repeatedly, and the purchase characteristics that correlated with failure.
Methodology
Samples arrived as sealed vials submitted by customers. Each was analyzed by LC-MS to confirm the sequence against the labeled compound's theoretical mass, and by reverse-phase HPLC at 214 nm to determine purity and quantify content against a reference standard. A sample was recorded as failing if the sequence did not match the label, if purity fell below 95%, or if measured content deviated from the labeled amount by more than 15%.
Headline Results
Roughly one in three samples failed at least one criterion. Outright wrong-compound results were the minority; underdosing and purity failures accounted for most of it. That pattern is economically rational from a counterfeiter's perspective — a diluted real peptide produces some effect and few complaints, while a wholly fake one generates refund requests.
Failure Mode One: Underdosing
The single most common finding was a correct sequence at materially less than the labeled quantity. Measured content clustered in bands well below label rather than scattering randomly, which is the signature of deliberate dilution during filling rather than of degradation. The practical consequence is subtle: users conclude a compound does not work for them, or escalate dose to compensate, without ever suspecting the vial.
Failure Mode Two: Wrong or Partial Sequence
Wrong-sequence results split into two kinds. Substitution — a cheaper peptide sold as an expensive one — was less common but the most consequential. Far more frequent were deletion and truncation products: synthesis failures where a residue is missing, giving material that is chemically close, indistinguishable by eye, and biologically inert. Longer sequences failed this way more often, consistent with synthesis difficulty scaling with chain length.
Failure Mode Three: Degradation and Handling
A meaningful share of failures involved products that were probably correct when made. Oxidation and deamidation signatures, poor lyophilization cake appearance, and low purity in samples shipped without cold packs during summer months all pointed to transit and storage rather than manufacture. Vendors who ship internationally by slow post at ambient temperature produced these results disproportionately.
What Predicted Failure
Several purchase characteristics correlated with failing results strongly enough to be useful before you buy.
What Was Not Contaminated
For balance: gross contamination was rare. We did not find a pattern of samples containing dangerous unrelated substances. The dominant risk in this market is not poisoning — it is paying for a compound you are not receiving in the amount stated, and drawing false conclusions about your own protocol as a result.
What We Take From This
A one-in-three failure rate means testing is not paranoia at these price points. It also means source selection does most of the work: the difference in failure rate between a licensed pharmacy channel and an anonymous reseller was larger than any other variable in the dataset.
Frequently Asked Questions
How many peptide samples fail testing?
In our dataset of 200+ samples, roughly one in three failed at least one criterion — most commonly content below label rather than an entirely wrong compound.
What is the most common problem with peptides?
Underdosing. Correct sequence, materially less material than the label claims.
Are fake peptides dangerous?
Gross contamination was rare in our testing. The dominant harms are financial and interpretive — paying for absent product and misreading a null result as a personal non-response.
References
Report a Safety Issue
If you've experienced health issues after using this peptide, please report it. Your report helps us track safety issues and protect other users.
Report Adverse Event